
Promises: We do not make medical promises.

We are in the planning stages of performing clinical trials in collaboration with New York University and the University of Miami. Collaborations: We have collaborated with doctors and scientists at major universities in the US, Canada, and Costa Rica including the University of California, San Diego, University of Utah, University of Western Ontario, University of Florida, University of Massachusetts, and the University of Costa Rica.We hope this will allow other doctors and scientists to further the science. Transparency: Our publications tell the world what we are doing and how we are doing it.Riordan has published a total of over 70 scientific articles, books and book chapters. Publications: We publish our treatment protocols, clinical trials, clinical observations, and theories in peer-reviewed literature.The characteristics of our organization which distinguish us from other stem cell treatment centers: We routinely interact with colleagues in the USA and internationally who are using stem cells as part of clinical trials in order to incorporate the most recent advancements into patient care.Īt the Stem Cell Institute, our mission is to be at the forefront of research of new treatment protocols for chronic diseases using adult stem cells, always according to the highest international bioethics standards, and offering, with transparency, honesty and human quality, treatments developed to improve the condition of our patients. Since opening our doors in 2006, we have performed over 10,000 procedures. Our medicine is founded on clinical use of stem cells.

The organization arose from the unmet need to provide stem cell therapies that have been shown by others to meet the bar of safety in Phase I trials, but are not yet widely available because efficacy has not been proven. Our team was assembled in 2005 to provide unbiased, scientifically-sound treatment options to patients with degenerative diseases. In close collaboration with universities and physicians worldwide, our comprehensive stem cell treatment protocols employ well-targeted combinations of allogeneic human umbilical cord stem cells and autologous bone marrow stem cells to treat diseases and conditions listed below.

The Stem Cell Institute (SCI) is one of the world’s leading adult stem cell therapy and research centers.
